Galenica Sante AG (GALE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.075x

Based on the latest financial reports, Galenica Sante AG (GALE) has a cash flow conversion efficiency ratio of 0.075x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF108.93 Million ≈ $137.72 Million USD) by net assets (CHF1.45 Billion ≈ $1.83 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Galenica Sante AG - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Galenica Sante AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GALE total liabilities for a breakdown of total debt and financial obligations.

Galenica Sante AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Galenica Sante AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Changchun High & New Technology Industries Group Inc SHE:000661	-0.019x
China Nonferrous Mining Corporation Limited STU:3N4	0.072x
Greek Organization of Football Prognostics S.A. AT:OPAP	0.457x
CONVATEC GRP UNSP.ADR /4 F:2CVU	N/A
JYSKE BK. UNS.ADR 1/5 DK1 F:JYS	N/A
Ho Chi Minh City Development Joint Stock Commercial Bank VN:HDB	0.622x
Sam Yang Foods KO:003230	0.104x
PCCW LTD ADR/10 HD-25 F:TH3C	N/A

Annual Cash Flow Conversion Efficiency for Galenica Sante AG (2014–2024)

The table below shows the annual cash flow conversion efficiency of Galenica Sante AG from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see GALE market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF1.55 Billion ≈ $1.96 Billion	CHF264.70 Million ≈ $334.66 Million	0.171x	+11.48%
2023-12-31	CHF1.48 Billion ≈ $1.87 Billion	CHF225.71 Million ≈ $285.36 Million	0.153x	-19.29%
2022-12-31	CHF1.25 Billion ≈ $1.58 Billion	CHF236.87 Million ≈ $299.47 Million	0.190x	-29.79%
2021-12-31	CHF1.23 Billion ≈ $1.56 Billion	CHF333.10 Million ≈ $421.12 Million	0.270x	+26.76%
2020-12-31	CHF1.05 Billion ≈ $1.33 Billion	CHF224.36 Million ≈ $283.65 Million	0.213x	-14.99%
2019-12-31	CHF999.54 Million ≈ $1.26 Billion	CHF250.44 Million ≈ $316.62 Million	0.251x	+34.78%
2018-12-31	CHF933.60 Million ≈ $1.18 Billion	CHF173.55 Million ≈ $219.41 Million	0.186x	+10.91%
2017-12-31	CHF861.51 Million ≈ $1.09 Billion	CHF144.40 Million ≈ $182.56 Million	0.168x	-64.28%
2016-12-31	CHF334.20 Million ≈ $422.53 Million	CHF156.82 Million ≈ $198.26 Million	0.469x	-8.17%
2015-12-31	CHF259.19 Million ≈ $327.69 Million	CHF132.44 Million ≈ $167.43 Million	0.511x	+45.94%
2014-12-31	CHF240.26 Million ≈ $303.76 Million	CHF84.12 Million ≈ $106.35 Million	0.350x	--

About Galenica Sante AG

SW:GALE Switzerland Medical Distribution

Market Cap

$5.24 Billion

CHF4.15 Billion CHF

Market Cap Rank

#3557 Global

#52 in Switzerland

Share Price

CHF83.25

Change (1 day)

+0.60%

52-Week Range

CHF82.75 - CHF102.80

All Time High

CHF102.80